Skip to main content Accessibility help
×
Home
  • Print publication year: 2005
  • Online publication date: February 2010

15 - Adolescent reproductive health and HIV

from Part II - General issues in the care of pediatric HIV patients
    • By Ligia Peralta, Associate Professor, Chief, Division of Adolescent Medicine, Director, Adolescent HIV Program, University of Maryland School of Medicine, Department of Pediatrics, Baltimore, MD, Sandra Cely, Assistant Professor, University of Maryland School of Medicine, Department of Pediatrics, Baltimore, MD
  • Edited by Steven L. Zeichner, National Cancer Institute, Bethesda, Maryland, Jennifer S. Read, National Cancer Institute, Bethesda, Maryland
  • Publisher: Cambridge University Press
  • DOI: https://doi.org/10.1017/CBO9780511544798.018
  • pp 205-243

Summary

Introduction

Reproductive and gynecological conditions common among adolescent girls, in general and among HIV-infected girls specifically, include delayed puberty; menstrual disorders, such as abnormal uterine bleeding (amenorrhea, hyperandrogenism, oligomenorrhea, and dysfunctional uterine bleeding [DUB]); dysmenorrhea; premenstrual syndrome; and pregnancy. Infectious gynecological conditions include vulvovaginal candidiasis, bacterial vaginosis (BV), trichomoniasis, atypical infections of the female genital tract, cervicitis, pelvic inflammatory disease (PID), human papillomavirus infection (HPV), and herpes simplex virus (HSV) infection. This chapter addresses common reproductive health disorders among HIV-infected adolescents, and also includes a description of risk factors unique to adolescents that contribute to the acquisition of sexually transmitted infections as well as age-appropriate recommendations for secondary prevention. Most reproductive health disorders among HIV-infected adolescent girls are best managed by an adolescent medicine physician. Certain patients, such as those with delayed puberty, amenorrhea, and hyperandrogenism should be managed in collaboration with an endocrinologist.

Common non-infectious reproductive and gynecological conditions

HIV-infected adolescents, similar to their uninfected counterparts, may experience delayed puberty and menstrual disorders. In addition to these conditions, we will discuss particular considerations related to contraception and pregnancy.

Delayed puberty

Diagnosing delayed puberty may be difficult due to wide ethnic and regional variations in normal development [1–5]. Pubertal maturation in girls begins with the acceleration of growth followed by onset of breast development (thelarche) between the ages of 8 and 13 years.

REFERENCES
Harlan, W. R., Harlan, E. A. & Grillo, G. P.Secondary sex characteristics of girls 12 to 17 years of age: The U.S. health examination survey. J. Pediatr. 96: 6 (1980), 1074–8
Rogol, A. D., Roemmich, J. N. & Clark, P. A.Growth at puberty. J. Adolesc. Health 31: 6 (Suppl) (2002), 192–200
Wheeler, M. D.Physical changes of puberty. Endocrinol. Metab. Clin. N. Am. 20: 1 (1991), 1–14
Sun, S. S., Schubert, C. M., Chumlea, W. C.. National estimates of the timing of sexual maturation and racial differences among U.S. Children. Pediatrics 110: 5 (2002), 911–19
Wu, T., Mendola, P. & Buck, G. M.Ethnic differences in the presence of secondary sex characteristics and menarche among U.S. girls: The third national health and nutrition examination survey, 1988–1994. Pediatrics 110: 4 (2002), 752–7
Zacharias, L., Rand, W. M. & Wurtman, R. J.A prospective study of sexual development and growth in American girls: The statistics of menarche. Obstetr. Gygnecol. Survey. 31 (1976), 325
Frisch, R. E. & Revelle, R.Menstrual cycles: Fatness as a determinant of minimum weight-for-height for their maintenance or onset. Science 185 (1974), 949
MacLure, M., Travis, L. B., Willett, W. & MacMahon, B.A prospective cohort study of nutrient intake and age at menarche. Am. J. Clin. Nutr. 54 (1991), 649
Chan, J. L., Bluher, S., Yiannakouris, N., Suchard, M. A., Kratzsch, J. & Mantzoros, C. S.Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51: 7 (2002), 2105–12
Palacio, A. C., Perez-Bravo F, , Santos, J. L., Schlesinger, L. & Monckeberg, F.Leptin levels ImmunoglobulinF-binding proteins in malnourished children: effect of weight gain. Nutrition 18: 1 (2002), 17–19
Laimer, M., Ebenbichler, C. F., Kaser, S.. Weight loss-increases soluble leptin receptor levels and the soluble receptor bound fraction of leptin. Obes. Res. 10: 7 (2002), 597–601
Shimizu, H., Shimomura, K., Negishi, M.. Circulating concentrations of soluble leptin receptor: influence of menstrual cycle and diet therapy. Nutrition 18: 4 (2002), 309–12
Beckett, P. R., Wong, W. W. & Copeland, K. C.Developmental changes in the relationship between IGF-I and body composition during puberty. Growth. Horm. IGF Res. 8: 4 (1998), 283–8
D'Ahmed, M. L., Ong, K. K., Morrell, D. J.. Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J. Clin. Endocrin. Metab. 84: 3 (1999), 899–905
Bideci, A., Cinaz, P., Hasanglu, A. & Turner, L.Leptin, insulin-like growth factor (IGF)-I and IGF binding protein-3 levels in children with constitutional delay of growth. J. Pediatr. Endocrinol. Metab. 15: 1 (2002), 41–6
D'Fors, H., Matsuoka, H., Bosaeus, I., Rosberg, S., Wikland, K. A. & Bjarnason, R.Serum leptin levels correlate with growth hormone secretion and body fat in children. J. Clin. Endocrinol. Metab. 84: 10 (1999), 3586–90
Simon, D.Puberty in chronically diseased patients. Horm. Res. 57 (Suppl. 2) (2002), 53–6
Sedlmeyer, I. L. & Palmert, M. R.Delayed puberty: analysis of a large case series from an academic center. J. Clin. Endocrinol. Metab. 87: 4 (2002), 1613–20
Albanese, A. & Stanhope, R.Investigation of delayed puberty. Clin. Endocrinology 43 (1995), 105–10
Mahoney, C. P.Evaluating the child with short stature. Pediatr. Clin. N. Am. 34 (1987), 825–49
Oerter, K. E., Uriarte, M. M., Rose, S. R., Barnes, K. M. & Cutler, G. B. Jr.Gonadotropin secretory dynamics during puberty in normal girls and boys. J. Clin. Endocrinol. Metab. 71: 5 (1990), 1251–8
Reiter, E. O. & Lee, P. A.Delayed puberty. Adolesc. Med. 13: 1 (2002), 101–18, ⅶ
Finkelstein, J. W., Susman, E. J., Chinchilli, V. M.. Effects of estrogen or testosterone on self-reported sexual responses and behaviors in hypogonadal adolescents. J. Clin. Endocrinol. Metab. 83: 7 (1998), 2281–5
Susman, E. J., Finkelstein, J. W., Chinchilli, V. M.. The effect of sex hormone replacement on behavior problems and moods in adolescents with delayed puberty. J. Pediatr. 133: 4 (1998), 521–5
Palmert, M. R., Malin, H. V. & Boepple, P. A.Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J. Clin. Endocrinol. Metab. 84 (1999), 415–23
Carpenter, S. Pediatric and Adolescent Gynecology. Philadelphia, PA: Lippincott Williams and Wilkins (2000)
Chirgwin, K. D., Feldman, J., Muneyyirci-Delale, O, Landesman, S. & Minkoff, H.Menstrual function in human immuno-deficiency virus-infected women without acquired immuno-deficiency syndrome. J. Acquired Immune Deficiency Syndrome Hum. Retrovirol. 12: 5 (1996), 489–94
Ellerbrock, T. V., Wright, T. C., Bus, T. J., Dole, P, Brudney, K. & Chiasson, M. A.Characteristics of menstruation in women infected with human immunodeficiency virus. Obstet. Gynecol. 87: 6 (1996), 1030–4
Mendelson, J. H., Teoh, S. K., Lange, U.. Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am. J. Psychiatry 145: 9 (1988), 1094–8
Pletcher, J. R. & Slap, G. B.Menstrual disorders. Amenorrhea. Pediatr. Clin. N. Am. 46: 3 (1999), 505–18
Grinspoon, S., Corcoran, C., Miller, K.. Body composition and endocrine function in women with acquired immuno-deficiency syndrome wasting. J. Clin. Endocrinol. Metab. 82: 5 (1997), 1332–7J
Golden, N. H.A review of the female athlete triad (amenorrhea, osteoporosis and disordered eating). Int. J. Adolesc. Med. Health. 14: 1 (2002), 9–17
Teoh, S. K., Lex, B. W., Mendelson, J. H., Mello, N. K. & Cochin, J.Hyperprolactinemia and macrocytosis in women with alcohol and polysubstance dependence. J. Stud. Alcohol 53: 2 (1992), 176–82
Block, R. I., Farinpour, R. & Schlechte, J. A.Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. 28: 2 (1991), 121–8
Efstratiades, M., Panitsa-Faflia, C. & Batrinos, M.Vaginal cytology in endocrinopathies. Acta Cytol. 27: 4 (1983), 421–5
Laufer, M. R., Floor, A. E., Parsons, K. E., Kuntz, K. M. & Barbieri, R. L.Hormone testing in women with adult-onset amenorrhea. Gynecol. Obstet. Invest. 40: 3 (1995), 200–3
Biller, B. M., Luciano, A., Crosignani, P. G.. Guidelines for the diagnosis and treatment of hyperprolactinemia. J. Reprod. Med. 44: 12 (Suppl.) (1999), 1075–84
Speroff, L., Glass, R. H. & Kase, N. G. Anovulation and the polycystic ovary. In?(eds.) Clinical Gynecology Endocrinology and Infertility. Philadephia, PA: Lippincott Williams and Wilkins (1999), pp. 487–513
Lobo, R. A. & Carmina, E.The importance of diagnosing the polycystic ovary syndrome. Ann. Intern. Med. 132: 12 (2000), 989–93
Stafford, D. E. & Gordon, C. M.Adolescent androgen abnormalities. Curr. Opin. Obstet. Gynecol. 14: 5 (2002), 445–51
Legro, R. S.The genetics of polycystic ovary syndrome. Am. J. Med. 98 (1995), 9S
Legro, R. S.Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J. Pediatr. Endocrinol. Metab. 15 (Suppl. 5) (2002), 1367–78
Strauss, J. F. 3rd & Dunaif, A.Molecular mysteries of polycystic ovary syndrome. Mol. Endocrinol. 13: 6 (1999), 800–5
Balen, A.Pathogenesis of polycystic ovary syndrome — the enigma unravels?Lancet. 18: 354 (9183) (1999), 966–7
McKenna, T. J.Pathogenesis and treatment of polycystic ovary syndrome. New Engl. J. Med. 318 (1998), 558
Avyad, C. K., Holeuwerger, R., Silva, V. C., Bordallo, M. A. & Breitenbach, M. M.Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol. Endocrinol. 15: 3 (2001), 170–7
Carmina, E., Wong, L., Chang, L.. Endocrine abnor-malities in ovulatory women with polycystic ovaries on ultrasound. Hum. Reprod. 12: 5 (1997), 905–9
Gordon, C. M.Menstrual disorders in adolescents: excess androgens and the polycystic ovary syndrome. Pediatr. Clin. N. Am. 46 (1999), 519–543
Arslanian, S. A., Lewy, V., Danadian, K. & Saad, R.Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J. Clin. Endocrinol. Metab. 87: 4 (2002), 1555–9
Bravender, T. & Emans, S. J.Menstrual disorders. Dysfunctional uterine bleeding. Pediatr. Clin. N. Am. 46: 3 (1999), 545–53, ⅶ
Munro, M. G.Dysfunctional uterine bleeding: advances in diagnosis and treatment. Curr. Opin. Obstet. Gynecol. 13: 5 (2001), 475–89
Shah, P. N., Smith, J. R., Wells, C., Barton, S. E., Kitchen, V. S. & Steer, P. J.Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet. Gynecol. 83: 3 (1994), 397–400
Munro, M. G.Abnormal uterine bleeding in the reproductive years. Part I —pathogenesis and clinical investigation. J. Am. Assoc. Gynecol. Laparosc. 6: 4 (1999), 393–416
Munro, M. G.Abnormal uterine bleeding in the reproductive years. Part II —medical management. J. Am. Assoc. Gynecol. Laparosc. 7: 1 (2000), 17–35
Kilbourn, C. L. & Richards, C. S.Abnormal uterine bleeding. Diagnostic considerations, management options. Postgrad. Med. 109: 1 (2001), 137–8, 141–4, 147–50
Dealy, M. F.Dysfunctional uterine bleeding in adolescents. Nurse. Pract. 23: 5 (1998), 2–3, 16, 18–20
Minjarez, D. A. & Bradshaw, K. D.Abnormal uterine bleeding in adolescents. Obstet. Gynecol. Clin. N. Am. 27: 1 (2000), 63–78
Speroff, L., Glass, R. H. & Kase, N. G. Dysfunctional uterine bleeding. In Clinical Gynecology Endocrinology and Infertility. Philadephia, PA: Lippincott Williams and Wilkins (1999), pp. 575–93
Klein, J. R. & Litt, I. F.Epidemiology of adolescent dysmenorrhea. Pediatrics 68: 5 (1981), 661–4
Eldering, J. A., Nay, M. G., Hoberg, L. M., Longcope, C. & McCracken, J. A.Hormonal regulation of endometrial prostaglandin F2 alpha production during the luteal phase of the rhesus monkey. Biol. Reprod. 49: 4 (1993), 809–15
Harel, Z., Lilly, C., Riggs, S., Vaz, R. & Drazen, J.Urinary leukotriene (LT) E(4) in adolescents with dysmenorrhea: a pilot study. J. Adolesc. Health 27: 3 (2000), 151–4
Harel, Z.A contemporary approach to dysmenorrhea in adolescents. Pediatr. Drugs. 4: 12 (2002), 797–805
Koike, H., Egawa, H., Ohtsuka, T., Yamaguchi, M., Ikenoue, T. & Mori, N.Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis. Prostaglandins Leukot. Essent. Fatty Acids. 46: 2 (1992), 133–7
Fedele, L., Bianchi, S., Bocciolone, L., Di Nola, G. & Parazzini, F.Pain symptoms associated with endometriosis. Obstet. Gynecol. 79: 5 (Pt 1) (1992), 767–9
Hornsby, P. P., Wilcox, A. J. & Weinberg, C. R.Cigarette smoking and disturbance of menstrual function. Epidemiology 9: 2 (1998), 193–8
Hendrix, S. L. & Alexander, N. J.Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 66: 6 (2002), 393–9
Chakmakjian, Z. H.A critical assessment of therapy for the premenstrual tension syndrome. J. Reprod. Med. 28: 8 (1983), 532–8
Raja, S. N., Feehan, M., Stanton, W. R. & McGee, R.Prevalence and correlates of the premenstrual syndrome in adol-escence. J. Am. Acad. Child. Adolesc. Psychiatry 31: 5 (1992), 783–9
Fisher, M., Trieller, K. & Napolitano, B.Premenstrual symptoms in adolescents. J. Adolesc. Health Care 10: 5 (1989), 369–75
Steiner, M. & Pearlstein, T.Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J. Clin. Psychiatry 61 (Suppl. 12) (2000), 17–21
Gianetto-Berruti, A. & Feyles, V.Premenstrual syndrome. Minerva Ginecol 54: 2 (2002), 85–95
Freeman, E. W.Premenstrual syndrome: current perspectives on treatment and etiology. Curr. Opin. Obstet. Gynecol. 9: 3 (1997), 147–53
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), Text Revision. Washington, Dendritic Cells: American Psychiatric Association 2000
Wenning, J. Premenstrual syndrome. In E. McAnarney, R. Kreipe, D. Orr & G. Comerci (eds.), Textbook of Adolescent Medicine. Philadelphia, PA: W. B. Saunders Company (1992), pp. 670–1
Johnson, S. R.Premenstrual syndrome therapy. Clin. Obstet. Gynecol. 41: 2 (1998), 405–21
UNFPA. The State of World Population 1997. New York: UNFPA 1997
Macro International. Women's Lives and Experiences: A Decade of Research Findings from the Demographic and Health Surveys Program. Calverton, MD: Macro International (1994) (footnote)
Child and adolescent health and development: Overview of CAH. Available at: http://www.who.int/child-adolescent-health/overview/ahd/adh_sheer.htm
Guest, F. Education and counseling: factors influencing education and counseling. In D. Kowal (ed.), Contraceptive Technology, 17th edn. New York: Ardent Media Inc. (1998), pp. 249–61
Derman, S. & Peralta, L.Postcoital contraception: present and future options. RU486 (Mifepristone). J. Adolesc. Health 16 (1995), 6–11
Hatcher, R., Trussel, J., Stewart, F. et al. Contraceptive Technology, 17th edn. New York: Ardent Media Inc. (1998)
Kuyoh, M. A., Toroitich-Ruto, C., Grimes, D. A., Schulz, K. F. & Gallo, M. F.Sponge versus diaphragm for contraception: a Cochrane review. Contraception 67: 1 (2003), 15–18
Joesoef, M. R., Karundeng, A., Runtupalit, C., Moran, J. S., Lewis, J. S. & Ryan, C. A.High rate of bacterial vaginosis among women with intrauterine devices in Manado, Indonesia. Contraception. 64: 3 (2001), 169–72
Morrison, C. S., Sekadde-Kigondu, C., Sinei, S. K., Weiner, D. H., Kwok, C. & Kokonya, D.Is the intrauterine device appropriate contraception for Human Immunodeficiency Virus-1-infected women?Br. J. Obstet. Gynaecol. Aug; 108: 8 (2001), 784–90
Belzer, M., Rogers, A. S., Camarca, M.. Contraceptive choices in Human Immunodeficiency Virus-infected and Human Immunodeficiency Virus at-risk adolescent females. J. Adolesc. Health 29S (2001), 93–100
Levin, L., Henry-Reid, L., Murphy, D. A.. Adolescent Medicine Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Research Network. Incident pregnancy rates in Human Immunodeficiency Virus-infected and Human Immunodeficiency Virus uninfected at-risk adolescents. J. Adolesc. Health 29S (2001), 101–8
Hatcher, R., Trussel, J., Stewart, F. et al. Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and reproductive health. In Contraceptive Technology, 17thedn. New York NY: Ardent Media Inc. (1998), pp. 141–78
Stone, A.Microbicides: a new approach to preventing Human Immunodeficiency Virus and other sexually transmitted infections. Nat. Rev. Drug. Discov. 1: 12 (2002), 977–85
Everett, S. A., Warrem, C. W., Santelli, J. S., Kann, L., Collins, J. L. & Kolbe, L. J.Use of birth control pills, condoms, and withdrawal among U.S. high school students. J. Adolesc. Health 27: 2 (2000), 12–18
Sivin, I. & Moo-Yong, A.Recent developments in contraceptive implants at the Population Council. Contraception 65: 1 (2002), 113–19
Garceau, R. J., Wajszczuk, C. J. & Kaunitz, A. M.Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. Contraception 62: 6 (2000), 289–95
Audet, M. C., Moreau, M., Koltun, W. D.. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. J. Am. Med. Assoc. 285: 18 (2001), 2347–54
Abrams, L. S., Skee, D., Matarajan, J. & Wong, F.A.Pharmacokinetic overview of Ortho Evra/Evra. Fertil. Steril. 77: 2 (Suppl. 2) (2002), S3–12
Smallwood, G. H., Meador, M. L., Lenihan, J. P., Shangold, G. A., Fisher, A. C. & Creasy, G. W.Efficacy and safety of a transdermal contraceptive system. Obstet. Gynecol. 98: 5 (Pt 1) (2001), 799–805
Sobel, J. Vulvovaginal candidiasis. In K. Holmes, F. Sparling, S. Lemon et al. (eds.), Sexually Transmitted Diseases, 3rd edn. New York, NY: McGraw-Hill (1999), pp. 629–39
Hatcher, R. A. & Guillebaud, J. The Pill: Combined oral contraceptive. In: D. Kowal (ed.), Contraceptive Technology 17thedn. New York: Ardent Media Inc. (1998), pp. 405–66
The Alan Guttmacher Institute. Why is Teenage Pregnancy Declining? The Roles of Abstinence, Sexual Activity and Contraceptive Use. Occasional Report. New York: Alan Guttmacher Institute; (1999)
Hatcher, R. A. Depo-Provera, Norplant, and progestin-only pills (minipills). In D. Kowal (ed.), Contraceptive Technology 17th edn. New York: Ardent Media Inc. (1998), pp. 467–509
D'Angelo, L., Belzer, M., Futterman, D., Peralta, L. & Sawyer, M.Reducing the Odds” at what cost: will routine testing of pregnant adolescents decrease perinatal transmission of Human Immunodeficiency Virus?J. Adolesc. Health. 27: 5 (2000), 296–7
Johansson, E., Brache, V., Alvarez, F.. Pharmacokinetic study of different dosing regimens of levonorgestrel for emergency contraception in healthy women. Hum. Reprod. 17: 6 (2002), 1472–6
Sivin, I., Mishell, D. R. Jr., Victor, A.. A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial. Contraception 24: 4 (1981), 359–76
Chu, S. Y., Hanson, D. L. & Jones, J. L.Pregnancy rates among women infected with human immunodeficiency virus. Adult/Adolescent Human Immunodeficiency Virus Spectrum of Disease Project Group. Obstet. Gynecol. 87: 2 (1996), 195–8
van Benthem, B. H. B., Vernazza, P., Coutinho, R. A. and Pris, M. The impact of pregnancy and menopause on Cluster of Differentiation4 cell counts in European Human Immunodeficiency Virus-infected women. Presented at National Institutes of Health Conference on Fertility and Systemic Hormones in Human Immunodeficiency Virus-infected and At-Risk Women; (Jan 13–14, 2003). McLean, VA (Abstr)
Ahdieh, L.Pregnancy and infection with human immunodeficiency virus. Clin. Obstet. Gynecol. 44: 2 (2001), 154–66
Mwanyumba, P., Claeys, P., Gaillard, C.. Correlation between maternal and infant Human Immunodeficiency Virus infection and low birth weight: A study in Mombasu, Kenya. J. Obstet. Gynecol. 21: 1 (2001), 27–31
Holmes, K. & Stamm, W. Lower genital tract infection syndromes in women. In K. Holmes, F. Sparling, S. Lemon et al. (eds.), Sexually Transmitted Diseases. 3rd edn. New York, NY: McGraw-Hill (1999), p. 766
Hashemi, F. B., Ghassemi, M., Faro, S., Aroutcheva, A. & Spear, G. T.Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J. Infect. Dis. 181: 5 (2000), 1574–80
Sturm-Ramirez, K., Gaye-Diallo, A., Eisen, G., Mboup, S. & Kanki, P. J.High levels of tumor necrosis factor-alpha and interleukin-1 beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J. Infect. Dis. 182: 2 (2000), 467–73
Cauci, S., Driussi, S., Guaschino, S., Isola, M. & Quadrifoglio, F.Correlation of local interleukin-1 beta levels with specific ImmunoglobulinA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis. Am. J. Reprod. Immunol. 47: 5 (2002), 257–64
Martin, H. L., Richardson, B. A., Nyange, P. M.. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180 (1999), 1863–8
Conley, L. J., Ellerbrock, T. V., Bush, T. J., Chiasson, M. A., Sawo, D. & Wright, T. C.Human Immunodeficiency Virus infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 359 (2002), 108–13
D'Angelo, L. J., Belzer, M.Futterman, D. & Peralta, L.Response to the joint statement on Human Immunodeficiency Virus screening. Pediatrics 105: 2 (2000), 467–8
Gerbase, A. C., Rowley, J. T. & Mertens, T. E.Global epidemiology of sexually transmitted diseases. Lancet 351 (Suppl. III) (1998), 2–4
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 51: Relative Risk-6 (2002), 1–78
Moscicki, A. B., Ellenberg, J. H. & Vermund, S. H.Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch. Pediatr. Adolesc. Med. 54: 2 (2000), 127–34
Jacobson, D., Mizell, S., Peralta, L.. Concordance of human papilloma virus in the cervix and urine of adolescents with a high prevalence of Human Papillomavirus. Pediatr. Infect. Dis. J. 19: 8 (2000), 722–8
Murphy, D. A., Durako, S. D., Moscicki, A. B.. and the Adolescent Medicine Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Research Network. No change in health risk behaviors over time among Human Immunodeficiency Virus-infected adolescents in care: role of psychological distress. J. Adolesc. Health 29S (2001), 57–63
Peralta, L., Durakos, S. J. & Ma, Y.Correlation between urine and cervical specimens for the detection of cervical Chlamydia trachomatis and Neisseria gonorrhoeae using ligase chain reaction in a cohort of Human Immunodeficiency Virus-infected and uninfected adolescents. J. Adolesc. Health 29S (2001), 87–92
Vermund, S. H., Wilson, C. M., Rogers, A. S., Partlow, C. & Moscicki, A. B.Sexually transmitted infections among Human Immunodeficiency Virus-infected and Human Immunodeficiency Virus uninfected high-risk youth in the Reaching for Excellence in Adolescent Care and Health study. J. Adolesc. Health 9S (2001), 49–56
Cu-Uvin, S., Hogan, J. W., Warren, D.. Prevalence of lower genital tract infections among human immuno-deficiency virus (Human Immunodeficiency Virus)-seropositive and high-risk Human Immunodeficiency Virus-seronegative women. Human Immunodeficiency Virus Epidemiology Research Study Group. Clin. Infect. Dis. 29: 5 (1999), 1145–50
Helfgott, A., Eriksen, N., Bundrick, C. M., Lorimor, R. & Eckhout, B.Vaginal infections in human immunodeficiency virus-infected women. Am. J. Obstet. Gynecol. 183: 2 (2000), 347–55
Wasserheit, J. N.Epidemiological synergy. Inter-relationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm. Dis. 19: 2 (1992), 61–77
Laga, M., Manoka, A., Kivuvu, M.. Non-ulcerative sexually transmitted diseases as risk factors for Human Immunodeficiency Virus transmission in women: results from a cohort study. Acquired Immune Deficiency Syndrome 7: 1 (1993), 95–102
Fleming, D. T. & Wasserheit, J. N.From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of Human Immunodeficiency Virus infection. Sex Transm. Infect. 75: 1 (1999), 3–17
Pilon, R., Sandstrom, P., Burchell, A. et al. A Transmitted Human Immunodeficiency Virus reverse transcriptase inhibitor resistance mutation stability in Antiretroviral Therapy-naive recent seroconverters: results of the polaris Human Immunodeficiency Virus seroconversion study. In XIV International Acquired Immune Deficiency Syndrome Conference (July 9 2002), Barcelona. (Abstr. Code No. TuPeB4611.)
Ostrowski, M. & Gough, K. A transmitted Human Immunodeficiency Virus reverse transcriptase inhibitor resistance mutation stability in Antiretroviral Therapy-naive recent seroconverters: Results of the polaris Human Immunodeficiency Virus seroconversion study. In XIV International Acquired Immune Deficiency Syndrome Conference (July 9, 2002), Barcelona
Greendale, G. A., Haas, S. T., Holbrook, K., Walsh, B., Schachter, J. & Phillips, R. S.The relationship of Chlamydia trachomatis infection and male infertility. Am. J. Public Health 83: 7 (1993), 996–1001
Robertson, D., McMillan, A. & Young, H. Clinical Practice in Sexually Transmissible Diseases, 2nd edn. Edinburgh: Churchill Livingstone (1989)
Goldenberg, R. L., Andrews, W. W., Yuan, A. C., MacKay, H. T. & St Louis, M. E.Sexually transmitted diseases and adverse outcomes of pregnancy. Clin. Perinatal 24: 1 (1997), 23–41
Moscicki, A. B., Ma, Y., Holland, C. & Vermund, S. H.Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J. Infect. Dis. 183: 6 (2001), 865–70
Irwin, K. L., Moorman, A. C. & Sullivan, M. J.Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet. Gynecol. 95: 4 (2000), 525–34
Manfredi, R., Alampi, G., Talo, S.. Silent oophoritis due to cytomegalovirus in a patient with advanced Human Immunodeficiency Virus disease. Int. J. STD Acquired Immune Deficiency Syndrome 11: 6 (2000), 410–12
Cohen, C. R., Sinei, S. & Reilly, M.Effect of human immuno-deficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J. Infect. Dis. 178: 5 (1998), 1352–8
Korn, A. P.Pelvic inflammatory disease in women infected with Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome Patient Care STDs 12: 6 (1998), 431–4
Ahmed, S., Lutalo, T. & Wawer, M.Human Immunodeficiency Virus incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. Acquired Immune Deficiency Syndrome 15: 16 (2001), 2171–9
Rudy, B. J., Crowley-Nowick, P. A. & Douglas, S. D.Immunology and the Reaching for Excellence in Adolescent Care and Health study: Human Immunodeficiency Virus immunology and preliminary findings. Reaching for Excellence in Adolescent Care and Health. J. Adolesc. Health 29: 3 (Suppl.) (2000), 39–48
Crowley-Nowick, P. A., Ellenberg, J. H., Vermund, S. H., Douglas, S. D., Holland, C. A. & Moscicki, A. B.Cytokine profile in genital tract secretions from adolescent women: impact of Human Immunodeficiency Virus, human papilloma virus and other sexually transmitted infections. J. Infect. Dis. 181 (2002), 939–45
Damme, L., Ramjee, G., Alary, M.. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on Human Immunodeficiency Virus transmission in female sex workers: a randomized controlled trial. Lancet 360: 9338 (2002), 971–7
Neinstein, L. S. (ed.) Adolescent Health Care. A Practical Guide, 4th edn. Philadelphia, PA: Lippincott Williams and Wilkins (2002)
California STD/Human Immunodeficiency Virus Prevention Training Center. Core STD Curriculum: Comprehensive Outlines for Clinical STD Management (1999)
Johnson, R. E., Newhall, W. J. & Papp, J. R.Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhea infections. MMWR 51: Relative Risk-15 (2002), 1–38 quiz CE1–4
Sobel, J. D., Kapernick, P. S. & Zervos, M.Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am. J. Obstet. Gynecol. 185: 2 (2001), 363–9
Hillier, S. & Holmes, K. K. Bacterial vaginosis. In K. Holmes, F. Sparling, S. Lemon (eds.), Sexually Transmitted Diseases, 3rd edn. New York, NY: McGraw-Hill (1999), pp. 563–86
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C., Eschenbach, D. & Holmes, K. K. Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations. In K. Holmes, F. Sparling, S. Lemon et al. (eds.), Sexually Transmitted Diseases, 3rd edn. New York, NY: McGraw-Hill (1999), p. 569
Joesef, M. R., Hillier, S. L., Josodiwondo, S. & Linnan, M.Reproducibility of a scoring system for Gram stain diagnosis of bacterial vaginosis. J. Clin. Microbiol. 29: 8 (1991), 1730–1
Ugwumadu, A., Hay, P. & Taylor-Robinson, D.Human Immunodeficiency Virus infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 9086 (1997), 1251
Ledru, S., Meda, N., Ledru, E., Bazie, A. J. & Chiron, J. P.Human Immunodeficiency Virus infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 9086 (1997), 1251–2
Jamieson, D. J., Duerr, A., Klein, R. S.. Longitudinal analysis of bacterial vaginosis: findings from the Human Immunodeficiency Virus epidemiology research study. Obstet. Gynecol. 98: 4 (2001), 656–63
Schwebke, J. R.Asymptomatic bacterial vaginosis: response to therapy. Am. J. Obstet. Gynecol. 183: 6 (2000), 1434–9
Livengood, C. H. 3rd, Soper, D. E., Sheehan, K. L.. Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis. Sex. Transm. Dis. 26: 3 (1999), 137–42
Paavonen, J., Mangioni, C., Martin, M. A. & Wajszczuk, C. P.Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet. Gynecol. 96: 2 (2000), 256–60
Ransom, S. B., McComish, J. F., Greenburg, R. & Tolford, D. A.Oral metronidazole vs. Metrogel Vaginal for treating bacterial vaginosis. Cost-effectiveness evaluation. J. Reprod. Med. 44: 4 (1999), 359–62
Hanson, J. M., McGregor, J. A., Hillier, S. L.. Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J. Reprod. Med. 45: 11 (2000), 889–96
Bannatyne, R. M. & Smith, A. M.Recurrent bacterial vaginosis and metronidazole resistance in Gardnerella vaginalis. Sex. Transm. Infect. 74: 6 (1998), 455–6
Hay, P. Sr.National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex. Transm. Infect. 75 (Suppl. 1) (1999), S16-18
McCormack, W. M., Covino, J. M. & Thomason, J. L.Comparison of clindamycin phosphate vaginal cream with triple sulfonamide vaginal cream in the treatment of bacterial vaginosis. Sex. Transm. Dis. 28: 10 (2001), 569–75
Sobel, J. D. Vulvovaginal candidiasis. In K. Holmes, F. Sparling, S. Lemon (eds.), Sexually Transmitted Diseases, 3rd edn., New York, NY: McGraw-Hill (1999), pp. 629–39
Sobel, J. D., Ohmit, S. E., Schuman, P.. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (Human Immunodeficiency Virus)-seropositive and at-risk Human Immunodeficiency Virus-seronegative women. J. Infect. Dis. 183: 2 (2000), 286–93
Sobel, J. D.Treatment of vaginal Candida infections. Expert Opin. Pharmacother. 3: 8 (2002), 1059–65
Jackson, D. J., Rakwar, J. P., Bwayo, J. J., Kreiss, J. K. & Moses, S.Urethral Trichomonas vaginalis infection and Human Immunodeficiency Virus transmission. Lancet 350: 9084 (1997), 1076
Krieger, J. & Alderete, J. Trichomonas vaginalis and Trichomoniasis. In K. Holmes, F. Sparling, S. Lemon, et al. (eds.), Sexually Transmitted Diseases, 3rd edn. New York, NY: McGraw-Hill (1999), pp. 587–604
Moodley, P., Wilkinson, D., Connolly, C., Moodley, J. & Sturm, A. W.Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis. 34: 4 (2002), 519–22
Moodley, P., Connolly, C. & Sturm, A. W.Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J. Infect. Dis. 185: 1 (2002), 69–73
Kamenga, M., Kamenga, M. C., Cock, K. M.. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast. Am. J. Obstet. Gynecol. 172: 3 (1995), 919–25
Friedmann, W., Schafer, A., Kretschmer, R. & Lobeck, H.Disseminated cytomegalovirus infection of the female genital tract. Gynecol. Obstet. Invest. 31: 1 (1991), 56–7
Centers for Disease Control and Prevention. Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Surveillance Report 2: 2 (2000), 5–44
Igra, V.Pelvic inflammatory disease in adolescents. Acquired Immune Deficiency Syndrome Patient Care STDs 12: 2 (1998), 109–24
Westrom, L. & Eschenbach, D. Pelvic inflammatory disease. In K. Holmes, F. Sparling, S. Lemon (eds.), Sexually Transmitted Diseases, 3rd edn. New York, NY: McGraw-Hill (1999), pp. 783–809
HRP Annual Technical Report 1995: Executive Summary. Available at: www.who.int/reproductive-health/publications/HRP_ATRs/1995/execsum.html
Irwin, K. L., Moorman, A. C., Sullivan, M. J.Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet. Gynecol. 95: 4 (2000), 525–34
Bersoff-Matcha, S. J., Horgan, M. M., Fraser, V. J., Mundy, L. M. & Stoner, B. P.Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J. Infect. Dis. 78: 4 (1998), 1174–7
Rice, P. A. & Schachter, J.Pathogenesis of pelvic inflammatory disease: What are the questions?J. Am. Med. Assoc. 266: 18 (1991), 2587–93
Slap, G. B., Forke, C. M., Cnaan, A.. Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J. Adol. Health. 18: 6 (1996), 397–403
Walker, C. K., Workowski, K. A., Washington, A. E., Soper, D. & Sweet, R. L.Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases. Clin. Infect. Dis. 28 (Suppl. 1) (1999), S29-36
Minkoff, H., Feldman, J., DeHovitz, J., Landesman, S. & Burk, R.A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am. J. Obstet. Gynecol. 178: 5 (1998), 982–6
Palefsky, J. M., Minkoff, H., Kalish, L. A.. Cervicovaginal human papillomavirus infection in human immuno-deficiency virus-1 (Human Immunodeficiency Virus)-positive and high-risk Human Immunodeficiency Virus-negative women. J. Natl. Cancer. Inst. 91: 3 (1999), 226–36
Shah, K. V., Munoz, A. & Klein, R. S. Prolonged persistence of genital human papillomavirus infections in Human Immunodeficiency Virus-infected women. Program and Abstracts of the 11th International Conference on Acquired Immune Deficiency Syndrome (July 7–12, 1996). Vancouver, Canada, p. 345 (Abst Tu.C.2466)
Sun, X. W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J. & Wright, T. C.Human papillomavirus infection in women infected with the human immunodeficiency virus. New Engl. J. Med. 337: 19 (1997), 1343–9
Jamieson, D. J., Duerr, A., Burk, R.. Characterization of genital human papillomavirus infection in women who have or who are at risk of having the Human Immunodeficiency Virus infection. Am. J. Obstet. Gynecol. 186: 1 (2002), 21–7
Ahdieh, L., Munoz, A., Vlahov, D., Trimble, C., Timpson, L. & Shah, K.Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am. J. Epidemiol. 151: 12 (2000), 1148–57
Brown, D. R., Bryan, J. T., Cramer, H., Katz, B. P., Handy, V. & Fife, K. H.Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients. J. Infect. Dis. 70 (1994), 759–65
Uberti-Foppa, C., Origoni, M., Maillard, M.. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in Human Immunodeficiency Virus-infected women. J. Med. Virol. 56 (1998), 133–7
Garzetti, G. G., Ciavattini, A., Butini, L., Vecchi, A. & Montroni, M.Cervical dysplasia in Human Immunodeficiency Virus-seropositive women: role of human papillomavirus infection and immune status. Gynecol. Obstet. Invest. 40: 1 (1995), 52–6
Massad, L. S., Riester, K. A. & Anastos, K. M.Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with Human Immunodeficiency Virus. Women's Interagency Human Immunodeficiency Virus Study Group. J. Acquired Immune Deficiency Syndrome 21: 1 (1999), 33–41
Delmas, M. C., Larsen, C. & Benthem, B.Cervical squamous intraepithelial lesions in Human Immunodeficiency Virus-infected women: prevalence, incidence, and regression. Acquired Immune Deficiency Syndrome 14: 12 (2000), 1775–84
Kobayashi, A., Darragh, T., Herndier, B.. Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on Human Immunodeficiency Virus status. Am. J. Pathol. 160: 1 (2002), 151–64
Kiviat, N., Kovtsky, L. A. & Paavonen, J. Cervical neoplasia and other STD related genital tract neoplasias. In K. Holmes, F. Sparling, S. Lemon et al. (eds.), Sexually Transmitted Diseases, 3rd edn. New York, NY: McGraw-Hill (1999), pp. 811–31
Chiasson, M. A.Declining Acquired Immune Deficiency Syndrome mortality in New York City. New York City Department of Health. Bull. N. Y. Acad. Med. 74: 1 (1997), 151–2
Weber, T., Chin, K., Sidhu, J. S. & Janssen, R. S. Prevalence of invasive cervical cancer among Human Immunodeficiency Virus-infected and uninfected hospital patients, 1994–1995. In Program and Abstracts of the 5th Conference on Retroviruses and Opportunistic Infections. (Chicago, Interleukin, 1998). Abstract 717
Phelps, R., Smith, D. K., Gardner, L. et al. Incidence of lung and invasive cervical cancer in Human Immunodeficiency Virus-infected women. In Program and Abstracts of the 13th International Conference on Acquired Immune Deficiency Syndrome, Durban, South Africa, July 9–14, 2000. [Abstract TuPeB3168]
Lomalisa, P., Smith, T. & Guidozzi, F.Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol. Oncol. 77: 3 (2000), 460–3
Maiman, M., Fruchter, R. G., Serur, E., Remy, J. C., Feuer, G. & Boyce, J.Human immunodeficiency virus infection and cervical neoplasia. Gynecol. Oncol. 38: 3 (1990), 377–82
Klevens, R. M., Fleming, P. L., Mays, M. A. & Frey, R.Characteristics of women with Acquired Immune Deficiency Syndrome and invasive cancer. Obstet. Gynecol. 88: 2 (1996), 269–73
Solomon, D., Darvey, D., Kurman, R.. The 2001 Bethesda System: terminology for reporting results of cervical cytology. J. Am. Med. Assoc. 287: 16 (2002), 2114–19
American College of Obstetricians and Gynecologists. Cervical Cytology: Evaluation and Management of Abnormalities. Technical Bulletin No. 183. Practice Guidelines August 1993
Wright, T. C., Moscarelli, R. D., Dole, P., Ellerbrock, T. V., Chiasson, M. A. & Vandevanter, N.Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet. Gynecol. 87: 4 (1996), 515–19
Holcomb, K., Abulafia, O., Matthews, R. P.. The significance of Atypical Squamous Cells of Undetermined Significance cytology in Human Immunodeficiency Virus-infected women. Gynecol. Oncol. 75: 1 (1999), 118–21
Duska, L. R., Flynn, C. F., Chen, A., Whall-Strojwas, D. & Goodman, A.Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet. Gynecol. 91: 2 (1998), 278–82
Kennedy, A. W., Salmieri, S. S., Wirth, S. L., Biscotti, C. V., Tuason, L. J. & Travarca, M. J.Results of the clinical evaluation of atypical glandular cells of undetermined significance (Atypical Glandular Cells of Undetermined Significance) detected on cervical cytology screening. Gynecol. Oncol. 63: 1 (1996), 14–18
Korn, A. P., Judson, P. L. & Zaloudek, C. J.Importance of atypical glandular cells of uncertain significance in cervical cytologic smears. J. Reprod. Med. 43: 9 (1998), 774–8
Fruchter, R., Maiman, M., Sedlis, A., Bartley, L., Camilien, L. & Arrastia, C. D.Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet. Gynecol. 87: 3 (1996), 338–44
Holcomb, K., Matthews, R. P., Chapman, J. E.. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in Human Immunodeficiency Virus-infected women. Gynecol. Oncol. 74: 3 (1999), 428–31
Maiman, M., Watts, D. H., Andersen, J., Clax, P., Merino, M. & Kendall, M. A.Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial. Obstet. Gynecol. 94: 6 (1999), 954–61
Fleming, D. T., McQuillan, G. M., Jhonson, R. E.. Herpes simplex virus type 2 in the United States, 1976 to 1994. New Engl. J. Med. 337: 16 (1997), 1105–11
Augenbraun, M., Feldman, J., Chirgwin, K.. Increased genital shedding of herpes simplex virus type 2 in Human Immunodeficiency Virus-seropositive women. Ann. Int. Med. 123: 11 (1995), 845–7
Mostad, S. B., Kreiss, J. K., Ryncarz, A. J.. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy and vitamin A deficiency. J. Infect. Dis. 181: 1 (2000), 58–63
Reyes, M., Graber, J. & Reeves, W. Acyclovir-resistant Herpes Simplex Virus: Preliminary results from a national surveillance system. Presented at International Conference on Emerging Infectious Diseases Mar 10 1998, Atlanta, GA (Abstr. No. 55)
Tapert, S. F., Aarons, G. A., Sedlar, G. R. & Brown, S. A.Adolescent substance use and sexual risk-taking behavior. J. Adolesc. Health 28: 3 (2001), 181–9
Boyer, C. B., Shafer, M., Wibbelsman, C. J., Seeberg, D., Teitle, E. & Lovell, N.Associations of sociodemographic, psychosocial and behavioral factors with sexual risk and sexually transmitted diseases in teen clinic patients. J. Adolesc. Health 27: 2 (2000), 102–11
Sanders-Phillips, K.Factors influencing Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome in women of color. Public Health Rep. 117 (Suppl. 1) (2002), S151–6